医薬品用金属検出機市場 – 2030年までの世界予測

Pharmaceutical Metal Detectors Market - Global forecast to 2030

医薬品用金属検出機市場 - 製品(錠剤、カプセル、粉末、液体検出器)、技術(磁場、多周波検出器、金属検出器付きX線検査)、および用途(包装検出、品質管理) - 2030年までの世界予測
Pharmaceutical Metal Detector Market by Product (Tablet, Capsule, Powder, Liquid Detectors), Technology (Magnetic Field, Multi-frequency Detector, X-ray Inspection with Metal Detectors), and Application (Packaging Detection, QC) - Global Forecast to 2030

商品番号 : SMB-83624

出版社MarketsandMarkets
出版年月2025年7月
ページ数247
図表数241
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

本レポートは、医薬品用金属探知機市場を製品、技術、用途、エンドユーザー、地域別に分析しています。また、市場成長に影響を与える要因(成長促進要因、阻害要因、機会、課題)についても分析しています。市場における機会と課題を分析し、市場リーダーの競争環境の詳細を提供します。さらに、マイクロマーケットの成長傾向を分析し、主要4地域とそれぞれの国における市場セグメントの収益を予測しています。

世界の医薬品用金属検出機市場は、2025年の1億5,710万米ドルから2030年には1億9,770万米ドルに達し、予測期間中に4.7%の年平均成長率(CAGR)を記録すると予測されています。この成長は主に、製品安全に関する厳格な規制要件と、汚染のない医薬品の需要の高まりによって推進されています。製品リコールや品質関連の懸念の増加により、メーカーは高度な検出技術の導入を余儀なくされています。自動化およびインテリジェントな金属検出システムの統合が進み、センサー感度やリアルタイムモニタリングの革新と相まって、市場拡大がさらに促進されると予想されます。GMPおよびFDA基準への準拠を重視することも、製薬会社による高精度検査装置への投資を促しています。さらに、業界関係者は、競争力を高め、プロセスの信頼性を確保するため、製品イノベーションや戦略的コラボレーションにますます積極的に取り組んでいます。

The global pharmaceutical metal detectors market is projected to reach USD 197.7 million by 2030 from USD 157.1 million in 2025, registering a CAGR of 4.7% during the forecast period. The growth is primarily driven by stringent regulatory requirements for product safety and the rising demand for contamination-free pharmaceutical products. Increasing cases of product recalls and quality-related concerns have compelled manufacturers to adopt advanced detection technologies. The growing integration of automated and intelligent metal detection systems, coupled with innovations in sensor sensitivity and real-time monitoring, is further expected to boost market expansion. Emphasis on compliance with GMP and FDA standards also encourages pharmaceutical companies to invest in high-precision inspection equipment. Moreover, industry players are increasingly engaging in product innovation and strategic collaborations to enhance their competitive edge and ensure process reliability.

医薬品用金属検出機市場 - 2030年までの世界予測 - chosareport.com
pharmaceutical-metal-detector-market-Overview

By product type, the tablet metal detectors segment accounted for the largest market share in 2024.

Tablet metal detectors dominated the pharmaceutical metal detectors market in 2024, primarily due to the widespread production of tablets across the global pharmaceutical industry. Tablets remain the most preferred and commonly manufactured solid dosage form because of their convenience, long shelf life, and patient compliance. The ease of integration, cost-efficiency, and reliability of tablet metal detectors have led to their wide adoption by both large pharmaceutical manufacturers and contract manufacturing organizations (CMOs). With rising global drug demand and tighter quality controls, the use of tablet metal detectors continues to expand, solidifying their position as the leading product type in this market.

By technology, the magnetic field detectors segment accounted for the largest share of the market in 2024.

Magnetic field detectors held the largest share of the pharmaceutical metal detectors market in 2024 due to their proven effectiveness, cost-efficiency, and adaptability across various pharmaceutical applications. Magnetic field detectors require less capital than more advanced systems like X-ray or multi-frequency detectors. For many pharmaceutical manufacturers, especially those operating in cost-sensitive or emerging markets, this affordability, paired with performance, makes magnetic field technology the preferred choice. Altogether, their combination of precision, versatility, and economic value solidifies their dominance in the pharmaceutical metal detectors market.

医薬品用金属検出機市場 - 2030年までの世界予測 - region
pharmaceutical-metal-detector-market-Region

By region, North America is expected to witness the highest growth rate during the forecast period.

The key factors driving market growth in North America include a high level of technological adoption and automation in pharmaceutical manufacturing facilities. This environment supports the integration of advanced metal detection systems that feature real-time data tracking, AI-based calibration, and automated rejection systems. Higher R&D spending and early adoption of Industry 4.0 practices have driven the use of multi-frequency and magnetic field detectors across North American facilities. This focus on innovation and operational efficiency further boosts the regional demand. The increasing number of drug recalls due to contamination risks and the growing export volume of US- and Canada-manufactured pharmaceutical products also necessitate robust inspection protocols, further reinforcing the dominance of North America in the pharmaceutical metal detectors market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
  • By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
  • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

  • By Company Type: Pharmaceutical Companies (50%), CDMOs (25%), Biopharmaceutical Companies (15%), and Other End Users (10%)
  • By Designation: Heads of Manufacturing/Production (40%), Quality Assurance Managers (30%), Regulatory Compliance Officers (20%), and Other Designations (10%)
  • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
医薬品用金属検出機市場 - 2030年までの世界予測 - ecosystem
pharmaceutical-metal-detector-market-Ecosystem

Research Coverage

This report studies the pharmaceutical metal detectors market by product, technology, application, end user, and region. The report also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Additionally, the report examines micromarkets concerning their growth trends and predicts the revenue of the market segments across four key regions and their respective countries.

Reasons to Buy the Report

The report can assist both established and smaller firms in assessing the market, which would enable them to capture a larger share. Companies that purchase the report could utilize one or a combination of the five strategies outlined below.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing number of product recalls due to metal contamination, stringent regulatory compliance mandates by regulatory authorities, and growing adoption of automation and inline quality control systems), restraints (high initial capital expenditure and recurring maintenance costs and operational challenges in detecting non-ferrous and foil-based contaminants), opportunities (focus on production optimization and high R&D investments and expansion of pharmaceutical exports and contract manufacturing), and challenges (integration complexity with existing production lines) are expected to influence the growth of the pharmaceutical metal detectors market.
  • Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and product launches in the pharmaceutical metal detectors market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for several types of pharmaceutical metal detection processes across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the pharmaceutical metal detectors market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the pharmaceutical metal detectors market.

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   24

1.3           STUDY SCOPE   24

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 24

1.3.2        INCLUSIONS & EXCLUSIONS       25

1.3.3        YEARS CONSIDERED      25

1.4           CURRENCY          26

1.5           STAKEHOLDERS               26

2               RESEARCH METHODOLOGY       28

2.1           RESEARCH APPROACH  28

2.1.1        SECONDARY DATA          29

2.1.2        PRIMARY DATA 31

2.2           MARKET SIZE ESTIMATION         34

2.3           MARKET BREAKDOWN & DATA TRIANGULATION                 40

2.4           MARKET SHARE ESTIMATION    41

2.5           STUDY ASSUMPTIONS  41

2.6           RISK ASSESSMENT           42

2.7           RESEARCH LIMITATIONS             42

2.7.1        METHODOLOGY-RELATED LIMITATIONS           42

2.7.2        SCOPE-RELATED LIMITATIONS                 42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       47

4.1           PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW          47

4.2           NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET OVERVIEW             48

4.3           PHARMACEUTICAL METAL DETECTORS MARKET: REGIONAL MIX 49

4.4           PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES      50

4.5           PHARMACEUTICAL METAL DETECTORS MARKET: DEVELOPING VS.

DEVELOPED ECONOMIES            51

5               MARKET OVERVIEW       52

5.1           INTRODUCTION              52

5.2           MARKET DYNAMICS       53

5.2.1        DRIVERS               53

5.2.1.1    Growing number of product recalls due to metal contamination                 53

5.2.1.2    Stringent regulatory compliance mandates      54

5.2.1.3    Growing adoption of automation and inline quality control systems  54

5.2.2        RESTRAINTS      55

5.2.2.1    High initial capital expenditure and recurring maintenance costs                 55

5.2.2.2    Operational challenges in detecting non-ferrous and foil-based contaminants         56

5.2.3        OPPORTUNITIES              56

5.2.3.1    Focus on production optimization and high R&D investment                 56

5.2.3.2    Expansion of pharmaceutical exports and contract manufacturing                 57

5.2.4        CHALLENGES    57

5.2.4.1    Integration complexity with existing production lines   57

5.3           TECHNOLOGY ANALYSIS             58

5.3.1        KEY TECHNOLOGIES     58

5.3.1.1    Electromagnetic induction technology              58

5.3.1.2    Multi frequency detection   58

5.3.2        COMPLEMENTARY TECHNOLOGIES       58

5.3.2.1    Conveyor and reject mechanism systems         59

5.3.2.2    Human–machine interface (HMI) and touchscreen controls                 59

5.4           PORTER’S FIVE FORCES ANALYSIS           59

5.4.1        INTENSITY OF COMPETITIVE RIVALRY 60

5.4.2        BARGAINING POWER OF BUYERS             61

5.4.3        BARGAINING POWER OF SUPPLIERS       61

5.4.4        THREAT OF SUBSTITUTES          61

5.4.5        THREAT OF NEW ENTRANTS      61

5.5           REGULATORY ANALYSIS               62

5.5.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             62

5.5.2        REGULATORY FRAMEWORK       66

5.5.2.1    North America      66

5.5.2.1.1 US           66

5.5.2.1.2 Canada   66

5.5.2.2    Europe   66

5.5.2.2.1 Germany                 66

5.5.2.3    Asia Pacific            67

5.5.2.3.1 China      67

5.5.2.3.2 Japan      67

5.5.2.3.3 India       67

5.5.2.3.4 Australia 67

5.5.2.4    Rest of the World 67

5.6           PATENT ANALYSIS          67

5.6.1        INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR PHARMACEUTICAL METAL DETECTORS MARKET,

JANUARY 2015–MAY 2025               68

5.6.2        LIST OF MAJOR PATENTS, 2023–2024        70

5.7           TRADE ANALYSIS             71

5.7.1        IMPORT DATA FOR HS CODE 854370, 2020–2024  71

5.7.2        EXPORT DATA FOR HS CODE 854370, 2020–2024  72

5.8           KEY CONFERENCES & EVENTS, 2025–2026              73

5.9           KEY STAKEHOLDERS & BUYING CRITERIA            73

5.9.1        KEY STAKEHOLDERS IN BUYING PROCESS           74

5.9.2        KEY BUYING CRITERIA  74

5.10         PRICING ANALYSIS          75

5.10.1      INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY PRODUCT TYPE,

2022–2024              75

5.10.2      INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL METAL DETECTORS,

BY REGION, 2022–2024    77

5.11         VALUE CHAIN ANALYSIS               78

5.12         ECOSYSTEM ANALYSIS  79

5.13         IMPACT OF AI/GEN AI ON PHARMACEUTICAL METAL DETECTORS MARKET    80

5.14         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       80

5.15         INVESTMENT & FUNDING SCENARIO     81

5.16         IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL METAL DETECTORS MARKET    82

5.16.1      INTRODUCTION              82

5.16.2      KEY TARIFF RATES          82

5.16.3      PRICE IMPACT ANALYSIS             83

5.16.4      IMPACT ON COUNTRY/REGION                83

5.16.4.1  US           83

5.16.4.2  Europe   84

5.16.4.3  APAC     84

5.16.5      IMPACT ON END-USE INDUSTRIES          84

5.16.5.1  Pharmaceutical companies 84

5.16.5.2  Contract Development and Manufacturing Organizations (CDMOs)              85

5.16.5.3  Other end users    85

6               PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT           86

6.1           INTRODUCTION              87

6.2           TABLET METAL DETECTORS     87

6.2.1        TABLET METAL DETECTORS TO DOMINATE MARKET DUE TO HIGH DEPLOYMENT IN LINE WITH TABLET PRESSES                 87

6.3           CAPSULE METAL DETECTORS   89

6.3.1        INCREASING NEED FOR PRECISION DURING CAPSULE FILLING AND PACKAGING TO BOOST ADOPTION           89

6.4           POWDER METAL DETECTORS   90

6.4.1        HIGH RISK OF CONTAMINATION IN DRY BULK PROCESSING TO DRIVE ADOPTION OF POWDER METAL DETECTORS       90

6.5           LIQUID METAL DETECTORS      92

6.5.1        INCREASING USE IN SYRUPS AND SUSPENSIONS REQUIRING BATCH PURITY TO SUPPORT MARKET GROWTH                 92

6.6           PIPELINE METAL DETECTORS   94

6.6.1        GROWING POPULARITY DUE TO EFFICIENCY IN CONTINUOUS FLOW SYSTEMS FOR SEMI-SOLIDS AND LIQUIDS TO FUEL MARKET GROWTH       94

7               PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY  96

7.1           INTRODUCTION              97

7.2           MAGNETIC FIELD DETECTORS 97

7.2.1        VERSATILITY OF MAGNETIC FIELD DETECTORS ACROSS VARIOUS PRODUCT TYPES AND PACKAGING FORMATS TO BOOST ADOPTION  97

7.3           MULTI-FREQUENCY DETECTORS             99

7.3.1        NEED FOR HIGH SENSITIVITY IN MIXED PRODUCT LINES TO BOOST DEMAND FOR MULTI-FREQUENCY METAL DETECTORS       99

7.4           X-RAY INSPECTION WITH METAL DETECTORS 101

7.4.1        SUPERIOR PERFORMANCE IN DETECTING DENSE AND NON-METALLIC CONTAMINANTS TO SUPPORT MARKET GROWTH             101

7.5           OTHER TECHNOLOGIES               103

8               PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION   104

8.1           INTRODUCTION              105

8.2           QUALITY CONTROL       105

8.2.1        STRINGENT GMP GUIDELINES EMPHASIZING END-TO-END PRODUCT INSPECTION TO CONTRIBUTE TO MARKET GROWTH             105

8.3           CONTAMINANT DETECTION     106

8.3.1        GROWING PRODUCT RECALLS AND HEALTH RISKS TO BOOST GROWTH             106

8.4           PACKAGING       107

8.4.1        RISING USE OF INLINE DETECTORS IN HIGH-SPEED PRODUCTION LINES TO SUPPORT MARKET GROWTH  107

8.5           COMPLIANCE    108

8.5.1        TIGHTER GLOBAL REGULATIONS AND INCREASED AUDIT PREPAREDNESS TO DRIVE GROWTH IN MARKET                 108

9               PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER            110

9.1           INTRODUCTION              111

9.2           PHARMACEUTICAL COMPANIES               111

9.2.1        HIGH VOLUME OF DRUG MANUFACTURING ACTIVITIES AND STRINGENT QA PROTOCOLS TO DRIVE GROWTH             111

9.3           CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS)         112

9.3.1        STRONG OUTSOURCING DEMAND TO PROPEL CDMO SEGMENTAL GROWTH  112

9.4           BIOPHARMACEUTICAL COMPANIES       113

9.4.1        RAPID EXPANSION OF BIOLOGICS MANUFACTURING CAPACITY TO BOOST METAL DETECTOR USAGE IN BIOPHARMACEUTICAL FIRMS   113

9.5           OTHER END USERS         114

10            PHARMACEUTICAL METAL DETECTORS MARKET, BY REGION                116

10.1         INTRODUCTION              117

10.2         NORTH AMERICA             118

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 118

10.2.2      US           122

10.2.2.1  Stringent FDA enforcement and contamination recalls to propel metal detector demand in US             122

10.2.3      CANADA               125

10.2.3.1  National biomanufacturing strategy to spur metal detector integration in Canada          125

10.3         EUROPE               128

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      128

10.3.2      GERMANY           132

10.3.2.1  Robust R&D and manufacturing excellence to drive market                 132

10.3.3      UK          135

10.3.3.1  Rising quality-driven inspection spending to boost market                 135

10.3.4      FRANCE                138

10.3.4.1  Government-backed reshoring efforts and sterile drug production to propel demand for metal detectors in France         138

10.3.5      ITALY    140

10.3.5.1  Country’s biopharmaceutical growth to support market uptake                 140

10.3.6      SPAIN    143

10.3.6.1  Public-sector manufacturing expansion and generics uptake to boost metal detector demand              143

10.3.7      REST OF EUROPE             145

10.4         ASIA PACIFIC     148

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 148

10.4.2      CHINA  152

10.4.2.1  Booming biologics hubs to fuel market growth in China                 152

10.4.3      JAPAN   155

10.4.3.1  Aging population and universal health coverage to drive adoption                 155

10.4.4      INDIA    158

10.4.4.1  Surging compliance upgrades and massive export ambitions to drive adoption       158

10.4.5      AUSTRALIA         161

10.4.5.1  Advanced pharmaceutical manufacturing to drive quality-centric investments            161

10.4.6      SOUTH KOREA  164

10.4.6.1  Innovation-driven pharma sector to promote advanced quality assurance                164

10.4.7      REST OF ASIA PACIFIC   166

10.5         REST OF THE WORLD    168

10.5.1      MACROECONOMIC OUTLOOK FOR REST OF THE WORLD 169

11            COMPETITIVE LANDSCAPE         172

11.1         OVERVIEW          172

11.2         KEY PLAYER STRATEGY/RIGHT TO WIN                172

11.3         REVENUE ANALYSIS, 2022–2024  174

11.4         MARKET SHARE ANALYSIS, 2024                 175

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 176

11.5.1      STARS   177

11.5.2      EMERGING LEADERS     177

11.5.3      PERVASIVE PLAYERS      177

11.5.4      PARTICIPANTS 177

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         179

11.5.5.1  Company footprint               179

11.5.5.2  Region footprint   180

11.5.5.3  Product footprint  181

11.5.5.4  Technology footprint           182

11.5.5.5  Application footprint            183

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        184

11.6.1      PROGRESSIVE COMPANIES         184

11.6.2      RESPONSIVE COMPANIES            184

11.6.3      DYNAMIC COMPANIES  184

11.6.4      STARTING BLOCKS         184

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 186

11.6.5.1  Detailed list of key startup/SME players          186

11.6.5.2  Competitive benchmarking of key emerging players/startups                 187

11.7         BRAND/PRODUCT COMPARISON             188

11.8         R&D EXPENDITURE OF KEY PLAYERS     189

11.9         COMPANY VALUATION & FINANCIAL METRICS 189

11.9.1      FINANCIAL METRICS      189

11.9.2      COMPANY VALUATION 190

11.10       COMPETITIVE SCENARIO             190

11.10.1   PRODUCT LAUNCHES   191

11.10.2   DEALS  192

11.10.3   EXPANSIONS     192

11.10.4   OTHER DEVELOPMENTS              192

12            COMPANY PROFILES      193

12.1         KEY PLAYERS     193

12.1.1      METTLER-TOLEDO INTERNATIONAL INC.           193

12.1.1.1  Business overview 193

12.1.1.2  Products offered   194

12.1.1.3  MnM view              195

12.1.1.3.1                Right to win           195

12.1.1.3.2                Strategic choices   195

12.1.1.3.3                Weaknesses & competitive threats     196

12.1.2      THERMO FISHER SCIENTIFIC INC.            197

12.1.2.1  Business overview 197

12.1.2.2  Products offered   198

12.1.2.3  MnM view              199

12.1.2.3.1                Right to win           199

12.1.2.3.2                Strategic choices   199

12.1.2.3.3                Weaknesses & competitive threats     199

12.1.3      ANRITSU CORPORATION             200

12.1.3.1  Business overview 200

12.1.3.2  Products offered   201

12.1.3.3  Recent developments           202

12.1.3.3.1                Product launches  202

12.1.3.4  MnM view              202

12.1.3.4.1                Right to win           202

12.1.3.4.2                Strategic choices   203

12.1.3.4.3                Weaknesses & competitive threats     203

12.1.4      MINEBEAMITSUMI INC. 204

12.1.4.1  Business overview 204

12.1.4.2  Products offered   205

12.1.4.3  Recent developments           206

12.1.4.3.1                Product launches  206

12.1.5      ILLINOIS TOOL WORKS INC.       207

12.1.5.1  Business overview 207

12.1.5.2  Products offered   208

12.1.5.3  Recent developments           209

12.1.5.3.1                Product launches  209

12.1.6      ERIEZ MANUFACTURING CO.     210

12.1.6.1  Business overview 210

12.1.6.2  Products offered   210

12.1.6.3  Recent developments           211

12.1.6.3.1                Deals      211

12.1.6.3.2                Other developments             211

12.1.6.4  MnM view              211

12.1.6.4.1                Right to win           211

12.1.6.4.2                Strategic choices   211

12.1.6.4.3                Weaknesses & competitive threats     212

12.1.7      CEIA S.P.A.          213

12.1.7.1  Business overview 213

12.1.7.2  Products offered   213

12.1.7.3  Recent developments           214

12.1.7.3.1                Product launches  214

12.1.7.3.2                Expansions             215

12.1.7.4  MnM view              215

12.1.7.4.1                Right to win           215

12.1.7.4.2                Strategic choices   215

12.1.7.4.3                Weaknesses & competitive threats     215

12.1.8      FORTRESS TECHNOLOGY INC.  216

12.1.8.1  Business overview 216

12.1.8.2  Products offered   216

12.1.8.3  Recent developments           217

12.1.8.3.1                Product launches  217

12.1.8.3.2                Deals      217

12.1.9      CASSEL MESSTECHNIK GMBH    218

12.1.9.1  Business overview 218

12.1.9.2  Products offered   218

12.1.9.3  Recent developments           219

12.1.9.3.1                Product launches  219

12.1.10   BUNTING            220

12.1.10.1                 Business overview 220

12.1.10.2                 Products offered   220

12.1.11   NIKKA DENSOK LIMITED             221

12.1.11.1                 Business overview 221

12.1.11.2                 Products offered   221

12.1.12   PRISMA INDUSTRIALE S.R.L.       223

12.1.12.1                 Business overview 223

12.1.12.2                 Products offered   223

12.1.13   WIPOTEC GMBH               224

12.1.13.1                 Business overview 224

12.1.13.2                 Products offered   224

12.1.14   DONGGUAN COSO ELECTRONIC TECH CO., LTD.                 225

12.1.14.1                 Business overview 225

12.1.14.2                 Products offered   225

12.1.15   VINSYST TECHNOLOGIES            226

12.1.15.1                 Business overview 226

12.1.15.2                 Products offered   226

12.2         OTHER PLAYERS              227

12.2.1      SED PHARMA     227

12.2.2      NEMESIS SRL      228

12.2.3      SOLLAU S.R.O.   229

12.2.4      TECHNOFOUR ELECTRONICS PVT. LTD.               230

12.2.5      INOS      231

12.2.6      ACG       232

12.2.7      ULTRACON ENGIMECH PVT. LTD.           233

12.2.8      DAS ELECTRONICS         234

12.2.9      UNIQUE EQUIPMENT    235

12.2.10   LODHA INTERNATIONAL LLP    236

13            APPENDIX           237

13.1         DISCUSSION GUIDE        237

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                243

13.3         CUSTOMIZATION OPTIONS        245

13.4         RELATED REPORTS         245

13.5         AUTHOR DETAILS           246

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES (USD)    26

TABLE 2                PHARMACEUTICAL METAL DETECTORS MARKET: STUDY ASSUMPTION ANALYSIS            41

TABLE 3                PHARMACEUTICAL METAL DETECTORS MARKET: RISK ASSESSMENT ANALYSIS  42

TABLE 4                PHARMACEUTICAL METAL DETECTORS MARKET: PORTER’S FIVE FORCES             59

TABLE 5                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  62

TABLE 6                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  63

TABLE 7                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  64

TABLE 8                REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 65

TABLE 10              IMPORT DATA FOR HS CODE 854370, BY COUNTRY, 2020–2024 (USD MILLION)     71

TABLE 11              EXPORT DATA FOR HS CODE 854370, BY COUNTRY, 2020–2024 (USD MILLION)     72

TABLE 12              PHARMACEUTICAL METAL DETECTORS MARKET: DETAILED LIST

OF KEY CONFERENCES & EVENTS, JULY 2025−JUNE 2026                 73

TABLE 13              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE  74

TABLE 14              KEY BUYING CRITERIA FOR PHARMACEUTICAL METAL DETECTORS, BY END USER          75

TABLE 15              INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY PRODUCT TYPE,

2022–2024 (USD)                76

TABLE 16              INDICATIVE PRICING ANALYSIS OF PHARMACEUTICAL METAL DETECTORS,

BY REGION, 2022–2024 (USD)      77

TABLE 17              PHARMACEUTICAL METAL DETECTORS MARKET: IMPACT OF AI/GEN AI                80

TABLE 18              US-ADJUSTED RECIPROCAL TARIFF RATES                 82

TABLE 19              PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            87

TABLE 20              TABLET METAL DETECTORS AVAILABLE IN MARKET               88

TABLE 21              TABLET METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     88

TABLE 22              CAPSULE METAL DETECTORS AVAILABLE IN MARKET               89

TABLE 23              CAPSULE METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     90

TABLE 24              POWDER METAL DETECTORS AVAILABLE IN MARKET               91

TABLE 25              POWDER METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     92

TABLE 26              LIQUID METAL DETECTORS AVAILABLE IN MARKET               93

TABLE 27              LIQUID METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     93

TABLE 28              PIPELINE METAL DETECTORS AVAILABLE IN MARKET               94

TABLE 29              PIPELINE METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     95

TABLE 30              PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            97

TABLE 31              MAGNETIC FIELD DETECTORS AVAILABLE IN MARKET               98

TABLE 32              MAGNETIC FIELD DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     99

TABLE 33              MULTI-FREQUENCY DETECTORS AVAILABLE IN MARKET               100

TABLE 34              MULTI-FREQUENCY DETECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 35              X-RAY INSPECTION WITH METAL DETECTORS AVAILABLE IN MARKET 102

TABLE 36              X-RAY INSPECTION WITH METAL DETECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            102

TABLE 37              OTHER PHARMACEUTICAL METAL DETECTION TECHNOLOGIES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               103

TABLE 38              PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            105

TABLE 39              PHARMACEUTICAL METAL DETECTORS MARKET FOR QUALITY CONTROL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     106

TABLE 40              PHARMACEUTICAL METAL DETECTORS MARKET FOR CONTAMINANT DETECTION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     107

TABLE 41              PHARMACEUTICAL METAL DETECTORS MARKET FOR PACKAGING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)       108

TABLE 42              PHARMACEUTICAL METAL DETECTORS MARKET FOR COMPLIANCE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            109

TABLE 43              PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            111

TABLE 44              PHARMACEUTICAL METAL DETECTORS MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)            112

TABLE 45              PHARMACEUTICAL METAL DETECTORS MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), BY COUNTRY,

2023–2030 (USD MILLION)            113

TABLE 46              PHARMACEUTICAL METAL DETECTORS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     114

TABLE 47              PHARMACEUTICAL METAL DETECTORS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               115

TABLE 48              PHARMACEUTICAL METAL DETECTORS MARKET, BY REGION,

2023–2030 (USD MILLION)            118

TABLE 49              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 120

TABLE 50              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 120

TABLE 51              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 121

TABLE 52              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     121

TABLE 53              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       122

TABLE 54              NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET,

BY END USER, 2023–2030 (USD MILLION)               122

TABLE 55              US: KEY MACROINDICATORS     123

TABLE 56              US: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            123

TABLE 57              US: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            124

TABLE 58              US: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            124

TABLE 59              US: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            125

TABLE 60              CANADA: KEY MACROINDICATORS         126

TABLE 61              CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            126

TABLE 62              CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            127

TABLE 63              CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            127

TABLE 64              CANADA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            128

TABLE 65              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 66              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            130

TABLE 67              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (HUNDRED UNITS)    130

TABLE 68              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            131

TABLE 69              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            131

TABLE 70              EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            132

TABLE 71              GERMANY: KEY MACROINDICATORS      133

TABLE 72              GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            133

TABLE 73              GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            134

TABLE 74              GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            134

TABLE 75              GERMANY: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            135

TABLE 76              UK: KEY MACROINDICATORS     136

TABLE 77              UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            136

TABLE 78              UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            137

TABLE 79              UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            137

TABLE 80              UK: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            138

TABLE 81              FRANCE: KEY MACROINDICATORS          138

TABLE 82              FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            139

TABLE 83              FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            139

TABLE 84              FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            140

TABLE 85              FRANCE: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            140

TABLE 86              ITALY: KEY MACROINDICATORS               141

TABLE 87              ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            141

TABLE 88              ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            142

TABLE 89              ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            142

TABLE 90              ITALY: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            143

TABLE 91              SPAIN: KEY MACROINDICATORS               143

TABLE 92              SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            144

TABLE 93              SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            144

TABLE 94              SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            145

TABLE 95              SPAIN: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            145

TABLE 96              REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 146

TABLE 97              REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     146

TABLE 98              REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       147

TABLE 99              REST OF EUROPE: PHARMACEUTICAL METAL DETECTORS MARKET,

BY END USER, 2023–2030 (USD MILLION)               147

TABLE 100            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 150

TABLE 101            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 150

TABLE 102            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (HUNDRED UNITS) 151

TABLE 103            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            151

TABLE 104            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            152

TABLE 105            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET,

BY END USER, 2023–2030 (USD MILLION)               152

TABLE 106            CHINA: KEY MACROINDICATORS             153

TABLE 107            CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            153

TABLE 108            CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            154

TABLE 109            CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            154

TABLE 110            CHINA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            155

TABLE 111            JAPAN: KEY MACROINDICATORS              156

TABLE 112            JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            156

TABLE 113            JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            157

TABLE 114            JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            157

TABLE 115            JAPAN: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            158

TABLE 116            INDIA: KEY MACROINDICATORS               159

TABLE 117            INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            159

TABLE 118            INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2023–2030 (USD MILLION)            160

TABLE 119            INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            160

TABLE 120            INDIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            161

TABLE 121            AUSTRALIA: KEY MACROINDICATORS   161

TABLE 122            AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            162

TABLE 123            AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            162

TABLE 124            AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            163

TABLE 125            AUSTRALIA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 126            SOUTH KOREA: KEY MACROINDICATORS                 164

TABLE 127            SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)                 164

TABLE 128            SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)            165

TABLE 129            SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            165

TABLE 130            SOUTH KOREA: PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER, 2023–2030 (USD MILLION)                 166

TABLE 131            REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               167

TABLE 132            REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     167

TABLE 133            REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       168

TABLE 134            REST OF ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET,

BY END USER, 2023–2030 (USD MILLION)               168

TABLE 135            REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               169

TABLE 136            REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET,

BY PRODUCT, 2023–2030 (HUNDRED UNITS)       170

TABLE 137            REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET,

BY TECHNOLOGY, 2023–2030 (USD MILLION)     170

TABLE 138            REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       171

TABLE 139            REST OF THE WORLD: PHARMACEUTICAL METAL DETECTORS MARKET,

BY END USER, 2023–2030 (USD MILLION)               171

TABLE 140            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET                 172

TABLE 141            PHARMACEUTICAL METAL DETECTORS MARKET: DEGREE OF COMPETITION    176

TABLE 142            PHARMACEUTICAL METAL DETECTORS MARKET: REGION FOOTPRINT 180

TABLE 143            PHARMACEUTICAL METAL DETECTORS MARKET: PRODUCT FOOTPRINT             181

TABLE 144            PHARMACEUTICAL METAL DETECTORS MARKET: TECHNOLOGY FOOTPRINT    182

TABLE 145            PHARMACEUTICAL METAL DETECTORS MARKET: APPLICATION FOOTPRINT     183

TABLE 146            PHARMACEUTICAL METAL DETECTORS MARKET: DETAILED LIST

OF KEY STARTUP/SME PLAYERS               186

TABLE 147            PHARMACEUTICAL METAL DETECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS      187

TABLE 148            PHARMACEUTICAL METAL DETECTORS MARKET: PRODUCT LAUNCHES,

JANUARY 2022 – MAY 2025              191

TABLE 149            PHARMACEUTICAL METAL DETECTORS MARKET: DEALS,

JANUARY 2022 – MAY 2025              192

TABLE 150            PHARMACEUTICAL METAL DETECTORS MARKET: EXPANSIONS,

JANUARY 2022–MAY 2025               192

TABLE 151            PHARMACEUTICAL METAL DETECTORS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025                 192

TABLE 152            METTLER-TOLEDO INTERNATIONAL INC.: COMPANY OVERVIEW   193

TABLE 153            METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS OFFERED    194

TABLE 154            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          197

TABLE 155            THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED             198

TABLE 156            ANRITSU CORPORATION: COMPANY OVERVIEW          200

TABLE 157            ANRITSU CORPORATION: PRODUCTS OFFERED                 201

TABLE 158            ANRITSU CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025     202

TABLE 159            MINEBEAMITSUMI INC.: COMPANY OVERVIEW                 204

TABLE 160            MINEBEAMITSUMI INC.: PRODUCTS OFFERED                 205

TABLE 161            MINEBEAMITSUMI INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025              206

TABLE 162            ILLINOIS TOOL WORKS INC.: COMPANY OVERVIEW          207

TABLE 163            ILLINOIS TOOL WORKS INC.: PRODUCTS OFFERED             208

TABLE 164            ILLINOIS TOOL WORKS INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025     209

TABLE 165            ERIEZ MANUFACTURING CO.: COMPANY OVERVIEW          210

TABLE 166            ERIEZ MANUFACTURING CO.: PRODUCTS OFFERED             210

TABLE 167            ERIEZ MANUFACTURING CO.: DEALS, JANUARY 2022–JUNE 2025  211

TABLE 168            ERIEZ MANUFACTURING CO.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025         211

TABLE 169            CEIA S.P.A.: COMPANY OVERVIEW           213

TABLE 170            CEIA S.P.A.: PRODUCTS OFFERED            213

TABLE 171            CEIA S.P.A.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025  214

TABLE 172            CEIA S.P.A.: EXPANSIONS, JANUARY 2022–JUNE 2025        215

TABLE 173            FORTRESS TECHNOLOGY INC.: COMPANY OVERVIEW          216

TABLE 174            FORTRESS TECHNOLOGY INC.: PRODUCTS OFFERED             216

TABLE 175            FORTRESS TECHNOLOGY INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025     217

TABLE 176            FORTRESS TECHNOLOGY INC.: DEALS, JANUARY 2022–JUNE 2025              217

TABLE 177            CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW          218

TABLE 178            CASSEL MESSTECHNIK GMBH: PRODUCTS OFFERED             218

TABLE 179            CASSEL MESSTECHNIK GMBH: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025     219

TABLE 180            BUNTING: COMPANY OVERVIEW             220

TABLE 181            BUNTING: PRODUCTS OFFERED              220

TABLE 182            NIKKA DENSOK LIMITED: COMPANY OVERVIEW                 221

TABLE 183            NIKKA DENSOK LIMITED: PRODUCTS OFFERED                 221

TABLE 184            PRISMA INDUSTRIALE S.R.L.: COMPANY OVERVIEW          223

TABLE 185            PRISMA INDUSTRIALE S.R.L.: PRODUCTS OFFERED             223

TABLE 186            WIPOTEC GMBH: COMPANY OVERVIEW                 224

TABLE 187            WIPOTEC GMBH: PRODUCTS OFFERED                 224

TABLE 188            DONGGUAN COSO ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW       225

TABLE 189            DONGGUAN COSO ELECTRONIC TECH CO., LTD.: PRODUCTS OFFERED        225

TABLE 190            VINSYST TECHNOLOGIES: COMPANY OVERVIEW          226

TABLE 191            VINSYST TECHNOLOGIES: PRODUCTS OFFERED             226

LIST OF FIGURES

FIGURE 1              PHARMACEUTICAL METAL DETECTORS MARKET SEGMENTATION

& REGIONAL SCOPE       24

FIGURE 2              RESEARCH DESIGN         28

FIGURE 3              PRIMARY SOURCES         31

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            33

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                33

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION                 34

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         35

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: METTLER-TOLEDO

INTERNATIONAL INC.   35

FIGURE 9              PHARMACEUTICAL METAL DETECTORS MARKET: SUPPLY-SIDE ANALYSIS (2024)                36

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)          37

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 38

FIGURE 12            TOP-DOWN APPROACH                39

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 40

FIGURE 14            PHARMACEUTICAL METAL DETECTORS MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      43

FIGURE 15            PHARMACEUTICAL METAL DETECTORS MARKET, BY TECHNOLOGY,

2025 VS. 2030 (USD MILLION)      44

FIGURE 16            PHARMACEUTICAL METAL DETECTORS MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      44

FIGURE 17            PHARMACEUTICAL METAL DETECTORS MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      45

FIGURE 18            PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHIC SNAPSHOT        46

FIGURE 19            GROWING NUMBER OF PRODUCT RECALLS DUE TO METAL CONTAMINATION TO DRIVE GROWTH IN PHARMACEUTICAL METAL DETECTORS MARKET            47

FIGURE 20            TABLET METAL DETECTORS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL METAL DETECTORS MARKET IN 2024                 48

FIGURE 21            NORTH AMERICA TO REGISTER HIGHEST CAGR IN MARKET THROUGHOUT FORECAST PERIOD                49

FIGURE 22            CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD         50

FIGURE 23            DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH

DURING FORECAST PERIOD       51

FIGURE 24            PHARMACEUTICAL METAL DETECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    53

FIGURE 25            PHARMACEUTICAL METAL DETECTORS MARKET: PORTER’S FIVE FORCES ANALYSIS       60

FIGURE 26           PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–MAY 2025)                 69

FIGURE 27            TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL

METAL DETECTOR PATENTS (JANUARY 2015–MAY 2025)                 70

FIGURE 28            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE  74

FIGURE 29            KEY BUYING CRITERIA FOR PHARMACEUTICAL METAL DETECTORS, BY END USER          74

FIGURE 30            PHARMACEUTICAL METAL DETECTORS MARKET: VALUE CHAIN ANALYSIS           78

FIGURE 31            PHARMACEUTICAL METAL DETECTORS MARKET: ECOSYSTEM ANALYSIS              79

FIGURE 32            PHARMACEUTICAL METAL DETECTORS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       81

FIGURE 33            PHARMACEUTICAL METAL DETECTORS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024                 81

FIGURE 34            PHARMACEUTICAL METAL DETECTORS MARKET: GEOGRAPHIC SNAPSHOT        117

FIGURE 35            NORTH AMERICA: PHARMACEUTICAL METAL DETECTORS MARKET SNAPSHOT            119

FIGURE 36            ASIA PACIFIC: PHARMACEUTICAL METAL DETECTORS MARKET SNAPSHOT            149

FIGURE 37            REVENUE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL

METAL DETECTORS MARKET (2022−2024)           174

FIGURE 38            MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL

METAL DETECTORS MARKET (2024)       175

FIGURE 39            PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 178

FIGURE 40            PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY FOOTPRINT             179

FIGURE 41            PHARMACEUTICAL METAL DETECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        185

FIGURE 42            PHARMACEUTICAL METAL DETECTORS MARKET:

BRAND/PRODUCT COMPARATIVE ANALYSIS     188

FIGURE 43            R&D EXPENDITURE OF KEY PLAYERS IN PHARMACEUTICAL METAL DETECTORS MARKET, 2022−2024                 189

FIGURE 44            EV/EBITDA OF KEY VENDORS   189

FIGURE 45            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                190

FIGURE 46            METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2024)      194

FIGURE 47            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             198

FIGURE 48            ANRITSU CORPORATION: COMPANY SNAPSHOT (2024)             201

FIGURE 49            MINEBEAMITSUMI INC.: COMPANY SNAPSHOT (2024)    205

FIGURE 50            ILLINOIS TOOL WORKS INC.: COMPANY SNAPSHOT (2024)             208